Mammalian target of rapamycin (mTOR) signaling, also modulated by PI3K-AKT, is on the most important biological pathways and it is implicated in various diseases ranging from cancer to neurodevelopmental pathologies (Dobyns and Mirzaa, 2019). The gene discussed is MTOR; the disease is cancer.